Leif Eriksson and his team have made some progress in their studies. A grant from the Swedish Cancer Society has been received and major investors have also shown interest in the project.

Have you made any progress in your research?

– Yes, the work is still progressing very well. We are conducting and have conducted a number of studies to further confirm the mechanism and interaction between the molecule and the target protein, and its effect in tumor cells, and everything continues to look extremely promising.

Where should we look to know the latest about your research on glioblastoma?

– I would recommend that you check EndGlioblastoma regularly. The goal is to continuously update with new information. However, it is important to remember that many of the trials and tests that are done take time, so it can sometimes take several months between rounds.

Tell us about your trip to San Diego!

– I recently participated in the Drug Discovery Chemistry (DDC) conference in San Diego, where I gave a talk on how to use AI to develop new drugs. I also had the opportunity to meet a number of other researchers and various pharmaceutical and service companies, as well as possible future investors.

Is it possible to register for participating in your future studies?

– Unfortunately, we are not at the point where we have such a list. However, I definitely understand that there are requests for it. When we are ready to test in humans, we will announce this, and our goal is of course to reach out as widely as possible, as early as possible. Exactly how and where such tests will take place is not something I have an answer to at the moment.

Have you received any applications for funding granted?

– The most recent grant came from the Swedish Cancer Society – they are doing a fantastic job in raising funds and supporting Swedish research into cancer (in all its forms).

Are any investors getting engaged?

– Discussions with slightly larger investors have begun, and it looks promising. Funding is the key to us being able to move forward as quickly as we wish and want, and we are always open to dialogue.